Cargando…

The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody

We sought to define the pathological features of myelin oligodendrocyte glycoprotein (MOG) antibody associated disorders (MOGAD) in an archival autopsy/biopsy cohort. We histopathologically analyzed 2 autopsies and 22 brain biopsies from patients with CNS inflammatory demyelinating diseases seroposi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Höftberger, Romana, Guo, Yong, Flanagan, Eoin P., Lopez-Chiriboga, A. Sebastian, Endmayr, Verena, Hochmeister, Sonja, Joldic, Damir, Pittock, Sean J., Tillema, Jan Mendelt, Gorman, Mark, Lassmann, Hans, Lucchinetti, Claudia F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181560/ https://www.ncbi.nlm.nih.gov/pubmed/32048003 http://dx.doi.org/10.1007/s00401-020-02132-y

Ejemplares similares

Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing
por: Sechi, Elia, et al.
Publicado: (2021)

CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies
por: Zhao-Fleming, Hannah H., et al.
Publicado: (2021)

Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease
por: Valencia‐Sanchez, Cristina, et al.
Publicado: (2022)

Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases
por: Peschl, Patrick, et al.
Publicado: (2017)

Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients
por: Fereidan‐Esfahani, Mahboubeh, et al.
Publicado: (2023)

Diagnostic challenges and pitfalls of myelin oligodendrocyte glycoprotein antibody–associated demyelination: Lessons from neuropathology
por: Höftberger, Romana, et al.
Publicado: (2019)

Clinical Significance of Myelin Oligodendrocyte Glycoprotein Autoantibodies in Patients with Typical MS Lesions on MRI
por: Zara, Pietro, et al.
Publicado: (2021)

Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination
por: Peschl, Patrick, et al.
Publicado: (2017)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
por: Sechi, Elia, et al.
Publicado: (2022)

Inflammatory demyelinating diseases of the central nervous system
por: Höftberger, Romana, et al.
Publicado: (2018)

Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders
por: Sechi, Elia, et al.
Publicado: (2021)

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
por: Tea, Fiona, et al.
Publicado: (2019)

Population-based study of “no evident disease activity” in MS
por: Parks, Natalie E., et al.
Publicado: (2018)

A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
por: Hochmeister, Sonja, et al.
Publicado: (2020)

Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Akaishi, Tetsuya, et al.
Publicado: (2016)

Frequency of New or Enlarging Lesions on MRI Outside of Clinical Attacks in Patients With MOG-Antibody–Associated Disease
por: Syc-Mazurek, Stephanie B., et al.
Publicado: (2022)

Complement-dependent cytotoxicity of human autoantibodies against myelin oligodendrocyte glycoprotein
por: Kohyama, Kuniko, et al.
Publicado: (2023)

Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis
por: Stiebel-Kalish, Hadas, et al.
Publicado: (2022)

Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination
por: Liu, Yiting, et al.
Publicado: (2017)

Antibody-mediated biorecognition of myelin oligodendrocyte glycoprotein: computational evidence of demyelination-related epitopes
por: Ierich, Jéssica Cristiane Magalhães, et al.
Publicado: (2019)

MRI-Negative Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Antibody Spectrum Demyelinating Disease
por: Pérez, Carlos A., et al.
Publicado: (2019)

Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes
por: Waters, Patrick, et al.
Publicado: (2019)

Connexin 43/47 channels are important for astrocyte/oligodendrocyte cross-talk in myelination and demyelination
por: Basu, Rahul, et al.
Publicado: (2018)

Quantitative magnetic resonance imaging reflects different levels of histologically determined myelin densities in multiple sclerosis, including remyelination in inactive multiple sclerosis lesions
por: Wiggermann, Vanessa, et al.
Publicado: (2023)

Dissection of complement and Fc-receptor-mediated pathomechanisms of autoantibodies to myelin oligodendrocyte glycoprotein
por: Mader, Simone, et al.
Publicado: (2023)

Author Correction: Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis
por: Stiebel-Kalish, Hadas, et al.
Publicado: (2023)

Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report
por: Gil-Perotin, Sara, et al.
Publicado: (2018)

New oligodendrocytes exhibit more abundant and accurate myelin regeneration than those that survive demyelination
por: Neely, Sarah A, et al.
Publicado: (2022)

Contribution of Oligodendrocytes, Microglia, and Astrocytes to Myelin Debris Uptake in an Explant Model of Inflammatory Demyelination in Rats
por: Cammarota, Mariarosaria, et al.
Publicado: (2023)

The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain
por: Haider, Lukas, et al.
Publicado: (2016)

Gas6 Increases Myelination by Oligodendrocytes and Its Deficiency Delays Recovery following Cuprizone-Induced Demyelination
por: Binder, Michele D., et al.
Publicado: (2011)

Mature oligodendrocytes bordering lesions limit demyelination and favor myelin repair via heparan sulfate production
por: Macchi, Magali, et al.
Publicado: (2020)

Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Associated Demyelinating Disease: Our Experience with this Distinct Syndrome
por: Pujari, Shripad S., et al.
Publicado: (2021)

Serum Neurofilament Light Chain Levels and Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Acquired Demyelinating Syndromes
por: Simone, Marta, et al.
Publicado: (2021)

Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination
por: Zirngibl, Martin, et al.
Publicado: (2022)

Glutamate delta-1 receptor regulates oligodendrocyte progenitor cell differentiation and myelination in normal and demyelinating conditions
por: Gakare, Sukanya G., et al.
Publicado: (2023)

Impaired myelin production due to an intrinsic failure of oligodendrocytes in mTORpathies
por: Gruber, Victoria‐Elisabeth, et al.
Publicado: (2021)

Myelination, Dysmyelination, and Demyelination
por: Jean Harry, G., et al.
Publicado: (1998)

Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease
por: Dinoto, Alessandro, et al.
Publicado: (2022)

The Glycosylation Site of Myelin Oligodendrocyte Glycoprotein Affects Autoantibody Recognition in a Large Proportion of Patients
por: Marti Fernandez, Iris, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6kkkc2q1jfmjcvhbm7bbv6o79u